期刊文献+

那他霉素在新西兰白兔眼组织中的浓度测定及眼组织分布考察 被引量:1

Investigation on Concentration Determination and Tissue Distribution of Natamycin in New Zealand White Rabbit Eyes
原文传递
导出
摘要 该研究建立了那他霉素(1)的LC-MS/MS分析方法,并测量了1在新西兰白兔眼部不同组织中的分布情况。结果显示,新西兰白兔经玻璃体腔注射给予1后,1在眼组织中广泛分布,且更多分布在眼后节。1在视网膜和玻璃体中的c_(max)(分别为46400和4620 ng/g)、AUC_(0→24)(分别为232000和29300 h·ng·g^(-1))均高于其他眼组织。给药24 h后,1在眼部各组织中的浓度依然较高,提示其保留时间较长。该研究建立的LC-MS/MS方法专属性高,结果可靠,可用于1的眼组织分布研究,为拓宽1用于眼部疾病的治疗提供了思路。 In this study,a LC-MS/MS analytical method was developed for determination of natamycin(1)to assess its distribution in various ocular tissues of New Zealand white rabbits.The results revealed that,after intravitreal administration of 1 to New Zealand white rabbits,1 was widely distributed in various ocular tissues,particularly in the posterior segment of the eye.The c_(max )and AUC_(0→24) of 1 in retina and vitreous were 46400 and 4620 ng/g,232000 and 29300 h·ng·g^(–1),respectively.The results demonstrated that the 1 amounts were higher in both retina and vitreous than in other ocular tissues.After 24 hours post-dosing,the drug concentration remained high level in all ocular tissues,indicating a longer retention of 1.Given this high specificity and reliable results,this established LC-MS/MS method is suitable for investigating distribution of 1 in ocular tissues and can be used to explore further potential treatments for ocular diseases with 1.
作者 孙璐瑶 缪峰 季金风 宋鑫 赵利媛 邱云良 SUN Luyao;MIAO Feng;JI Jinfeng;SONG Xin;ZHAO Liyuan;QIU Yunliang(School of Pharmacy,Anhui University of Traditional Chinese Medicine,Hefei 230012;InnoStar Biotechnology Nantong Co.,Ltd.,Nantong 226133;Yangtze Delta Drug Advanced Research Institute,Nantong 226133;Shanghai Innostar Biotech Co.,Ltd.,Shanghai 201203)
出处 《中国医药工业杂志》 EI CAS CSCD 2024年第4期533-539,共7页 Chinese Journal of Pharmaceuticals
关键词 那他霉素 LC-MS/MS 定量分析 组织分布 玻璃体腔注射 natamycin LC-MS/MS quantitative analysis tissue distribution intravitreal injection
  • 相关文献

参考文献2

二级参考文献22

  • 1Pflugfelder SC, Flynn HW Jr, Zwickey TA, Forster RK, Tsiligianni A, Culbertson WW, Mandelbaum S. Exogenous fungal endophthalitis. 1988;95(1):19-30.
  • 2Wykoff CC, Flynn HW Jr, Miller D, Scott IU, Alfonso EC. Exogenous fungal endophthalmitis: microbiology and clinical outcomes.2008; 115(9):1501-1507.e 1-2.
  • 3Shen YC, Wang CY, Tsai HY, Lee HN. Intraeameral voriconazole injection in the treatment of fungal endophthalmitis resulting from keratitis. 2010; 149(6): 916-921.
  • 4Riddell J 4th, Comer GM, Kauffman CA. Treatment of endogenous fungal endophthalmitis: focus on new antifungal agents.2011;52 (5):648-653.
  • 5Xie L, Zhai H, Zhao J, Sun S, Shi W, Dong X. Antifungal susceptibility for common pathogens of fungal keratitis in Shandong Province, China. 2008;146(2 ):260- 265.
  • 6Xie L, Dong X, Shi W. Treatment of fungal keratitis by penetrating keratoplasty.2001;8 5(9 ):107 0-107 4.
  • 7Chakrabarti A, Shivaprakash MR, Singh R, Tarai B, George VK, Fomda BA, Gupta A. Fungal endophthalmitis: fourteen years' experience from a center in India. 2008;28(10):1400-1407.
  • 8Sanders N. Penetrating keratoplasty in treatment of fungus keratitis. 1970;70(1 ):24-30.
  • 9Xie L, Hu J, Shi W. Treatment failure after lamellar keratoplasty for fungal keratitis.2008;115(1):33-36.
  • 10Shen X, Xu G. Vitrectomy for endogenous fungal endophthalmitis. 2009; 17(3):148-152.

共引文献10

同被引文献8

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部